We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00577694
Recruitment Status : Terminated (funding unavailable)
First Posted : December 20, 2007
Last Update Posted : October 12, 2015
National Cancer Institute (NCI)
Genzyme, a Sanofi Company
Information provided by (Responsible Party):
UNC Lineberger Comprehensive Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : July 2010
  Study Completion Date : August 2015